These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 39270150)

  • 1. The Adverse Effects of Commonly Prescribed Antiseizure Medications in Adults With Newly Diagnosed Focal Epilepsy.
    Barnard SN; Chen Z; Kanner AM; Holmes MG; Klein P; Abou-Khalil BW; Gidal BE; French J; Perucca P;
    Neurology; 2024 Oct; 103(7):e209821. PubMed ID: 39270150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of antiseizure medication utilization in the Human Epilepsy Project.
    Fox J; Barnard S; Agashe SH; Holmes MG; Gidal B; Klein P; Abou-Khalil BW; French J;
    Epilepsia; 2023 Dec; 64(12):3196-3204. PubMed ID: 37846772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Major Congenital Malformations and Exposure to Antiseizure Medication Monotherapy.
    Battino D; Tomson T; Bonizzoni E; Craig J; Perucca E; Sabers A; Thomas S; Alvestad S; Perucca P; Vajda F;
    JAMA Neurol; 2024 May; 81(5):481-489. PubMed ID: 38497990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of long-term efficacy, tolerability, and safety of oxcarbazepine, lamotrigine, and levetiracetam in patients with newly diagnosed focal epilepsy: An observational study in the real world.
    Li R; Zhou Q; Ou S; Wang Y; Li Y; Xia L; Pan S
    Epilepsy Res; 2020 Oct; 166():106408. PubMed ID: 32679487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
    Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011412. PubMed ID: 29243813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
    Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011412. PubMed ID: 28661008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
    Marson A; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton C; Hughes DA; Williamson P; Baker GA; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE;
    Lancet; 2021 Apr; 397(10282):1363-1374. PubMed ID: 33838757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Antiseizure Drug Monotherapy and Mortality for Patients With Poststroke Epilepsy.
    Larsson D; Baftiu A; Johannessen Landmark C; von Euler M; Kumlien E; Åsberg S; Zelano J
    JAMA Neurol; 2022 Feb; 79(2):169-175. PubMed ID: 34902006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
    Nevitt SJ; Sudell M; Cividini S; Marson AG; Tudur Smith C
    Cochrane Database Syst Rev; 2022 Apr; 4(4):CD011412. PubMed ID: 35363878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy.
    Cerulli Irelli E; Cocchi E; Morano A; Gesche J; Caraballo RH; Lattanzi S; Strigaro G; Catania C; Ferlazzo E; Pascarella A; Casciato S; Quarato P; Pizzanelli C; Pulitano P; Giuliano L; Viola V; Mostacci B; Fortunato F; Marini C; Di Gennaro G; Gambardella A; Labate A; Operto FF; Giallonardo AT; Baykan B; Beier CP; Di Bonaventura C;
    JAMA Neurol; 2023 Nov; 80(11):1174-1181. PubMed ID: 37782485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential antiseizure medication sensitivity of the Affective Reactivity Index: A randomized controlled trial in new-onset pediatric focal epilepsy.
    Loring DW; Meador KJ; Shinnar S; Gaillard WD; Wheless JW; Kessler SK; Conry JA; Berl MM; Burns TG; Glauser TA; Kinkead B; Cnaan A
    Epilepsy Behav; 2020 Jan; 102():106687. PubMed ID: 31816478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: A German longitudinal analysis from 2008 to 2020.
    Hochbaum M; Kienitz R; Rosenow F; Schulz J; Habermehl L; Langenbruch L; Kovac S; Knake S; von Podewils F; von Brauchitsch S; Hamacher M; Strzelczyk A; Willems LM
    Epilepsy Behav; 2022 May; 130():108666. PubMed ID: 35339390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
    Lancet Neurol; 2018 Jun; 17(6):530-538. PubMed ID: 29680205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Tudur Smith C; Weston J; Marson AG
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001031. PubMed ID: 29952431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of lamotrigine and oxcarbazepine monotherapy for pediatric focal epilepsy: An observational study.
    Hur YJ
    Seizure; 2018 Aug; 60():123-126. PubMed ID: 29957441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in Antiseizure Medication Initiation, Switch, or Termination in Patients With Newly Diagnosed Epilepsy: A Nationwide Study.
    Bolin K; Patric B; Tomson T
    Neurology; 2024 Jul; 103(2):e209500. PubMed ID: 38870473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiseizure Medication Concentrations During Pregnancy: Results From the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) Study.
    Pennell PB; Karanam A; Meador KJ; Gerard E; Kalayjian L; Penovich P; Matthews A; McElrath TM; Birnbaum AK;
    JAMA Neurol; 2022 Apr; 79(4):370-379. PubMed ID: 35157004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence rates of severe cutaneous adverse reactions due to antiseizure medication: A nationwide study using health claims data in Korea.
    Chung SJ; Ahn KM; Oh JH; Shim JS; Park HW
    Epilepsia; 2021 Jan; 62(1):250-257. PubMed ID: 33188522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability.
    Bjørk MH; Zoega H; Leinonen MK; Cohen JM; Dreier JW; Furu K; Gilhus NE; Gissler M; Hálfdánarson Ó; Igland J; Sun Y; Tomson T; Alvestad S; Christensen J
    JAMA Neurol; 2022 Jul; 79(7):672-681. PubMed ID: 35639399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.